TIM3 comes of age as an inhibitory receptor

Y Wolf, AC Anderson, VK Kuchroo - Nature Reviews Immunology, 2020 - nature.com
T cell immunoglobulin and mucin domain-containing protein 3 (TIM3), a member of the TIM
family, was originally identified as a receptor expressed on interferon-γ-producing CD4+ and …

T cells: warriors of SARS-CoV-2 infection

P de Candia, F Prattichizzo, S Garavelli… - Trends in …, 2021 - cell.com
Severe infection with severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is
characterized by massive cytokine release and T cell loss. The exaggerated host immune …

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

JA Fraietta, SF Lacey, EJ Orlando, I Pruteanu-Malinici… - Nature medicine, 2018 - nature.com
Tolerance to self-antigens prevents the elimination of cancer by the immune system,. We
used synthetic chimeric antigen receptors (CARs) to overcome immunological tolerance and …

CD4 T-cell exhaustion: does it exist and what are its roles in cancer?

AM Miggelbrink, JD Jackson, SJ Lorrey… - Clinical Cancer …, 2021 - AACR
In chronic infections and in cancer, persistent antigen stimulation under suboptimal
conditions can lead to the induction of T-cell exhaustion. Exhausted T cells are …

T‐cell exhaustion in HIV infection

C Fenwick, V Joo, P Jacquier, A Noto… - Immunological …, 2019 - Wiley Online Library
The T‐cell response is central in the adaptive immune‐mediated elimination of pathogen‐
infected and/or cancer cells. This activated T‐cell response can inflict an overwhelming …

Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation

AC Anderson, N Joller, VK Kuchroo - Immunity, 2016 - cell.com
Co-inhibitory receptors, such as CTLA-4 and PD-1, have an important role in regulating T
cell responses and have proven to be effective targets in the setting of chronic diseases …

Tim‐3 and its role in regulating anti‐tumor immunity

M Das, C Zhu, VK Kuchroo - Immunological reviews, 2017 - Wiley Online Library
Immunotherapy is being increasingly recognized as a key therapeutic modality to treat
cancer and represents one of the most exciting treatments for the disease. Fighting cancer …

CD8 T cell exhaustion during chronic viral infection and cancer

LM McLane, MS Abdel-Hakeem… - Annual review of …, 2019 - annualreviews.org
Exhausted CD8 T (Tex) cells are a distinct cell lineage that arise during chronic infections
and cancers in animal models and humans. Tex cells are characterized by progressive loss …

TIM-3: An update on immunotherapy

L Zhao, S Cheng, L Fan, B Zhang, S Xu - International …, 2021 - Elsevier
T cell immunoglobulin and mucin domain 3 (TIM-3) was originally found to be expressed on
the surface of Th1 cells, acting as a negative regulator and binding to the ligand galectin-9 to …

Targeting the latent reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - cell.com
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …